Keep up to date with Isogenica’s latest news on collaborations and press releases.
Isogenica and Frederick National Laboratory for Cancer Research team up to discover novel antibody therapeutics
UK-based antibody engineering experts Isogenica are proud to announce a new collaboration with the Frederick National Laboratory for Cancer Research in Maryland USA.
Wellmarker Bio and Isogenica today announced the signing of a Memorandum of Understanding (MoU). The MoU will serve as a foundation for increased cooperation between the two companies.
Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Isogenica are furthering their collaboration with Phenotypeca, whose platform will deploy yeast-display for multivalent...
Catch up on Isogenica’s latest activities.
Announcing a new collaboration with Arvinas Isogenica is pleased to announce a technology license agreement with Arvinas, who will leverage Isogenica’s CIS Display technology in support of advancing...
As part of our KTP partnership between Aston University and Nottingham University, we’re developing and integrating an ML-assisted pipeline for faster discovery and optimisation of VHH antibodies for next-generation biotherapeutics.
Read how AstraZeneca researchers screened our highly diverse, fully synthetic VHH library for novel antibodies against phospholamban.